AbbVie expands Oxford R&D facility as part of £120 million-plus investment

3

Nov 4 (Reuters) – AbbVie has expanded its UK research and development facility in Oxford as part of a more than £120 million ($161 million) investment, the US drugmaker said on Wednesday. The

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)